Get the Stockscreener App
3.04
5.56%
0.16
After Hours:
3.14
0.10
+3.29%
Nuwellis Inc stock is traded at $3.04, with a volume of 118.83K.
It is up +5.56% in the last 24 hours and down -42.86% over the past month.
Nuwellis Inc is a commercial-stage medical device company focused on developing, manufacturing, and commercializing medical devices used in ultrafiltration therapy, including the Aquadex FlexFlow and the Aquadex SmartFlow systems. The Aquadex Smartflow System removes excess fluid from patients suffering from fluid overload who have not responded to medical management, including diuretics. Nuwellis has one reportable segment: fluid overload.
See More
Previous Close:
$2.88
Open:
$2.9066
24h Volume:
118.83K
Relative Volume:
1.63
Market Cap:
$280.29K
Revenue:
$8.77M
Net Income/Loss:
$-19.05M
P/E Ratio:
-0.0474
EPS:
-64.1076
Net Cash Flow:
$-11.60M
1W Performance:
-3.49%
1M Performance:
-42.86%
6M Performance:
-95.66%
1Y Performance:
-98.83%
1-Day Range:
$2.87
$3.20
1-Week Range:
$2.7501
$3.50
52-Week Range:
$2.7501
$908.25
Nuwellis Inc Stock (NUWE) Company Profile
Name
Nuwellis Inc
Sector
Industry
Phone
952-345-4200
Address
12988 VALLEY VIEW ROAD, EDEN PRAIRIE
Compare NUWE vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
NUWE
Nuwellis Inc
|
3.04 | 280.29K | 8.77M | -19.05M | -11.60M | -64.11 |
ABT
Abbott Laboratories
|
93.93 | 163.61B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
329.78 | 126.42B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
83.87 | 107.36B | 36.36B | 4.84B | 5.43B | 3.7212 |
BSX
Boston Scientific Corp
|
44.77 | 66.54B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
92.21 | 53.09B | 6.30B | 1.07B | 1.09B | 1.8406 |
Nuwellis Inc Stock (NUWE) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-29-24 | Initiated | ROTH MKM | Buy |
Nuwellis Inc Stock (NUWE) Latest News
Nuwellis names Mike McCormick as CEO - MSN
NUWE Q1 2026 Earnings: Massive EPS Miss as Company Reports No RevenueNegative Surprise Momentum - dars.gov.et
Form DEF 14A Nuwellis Inc For: 7 July By Investing.com - Investing.com Nigeria
Nuwellis (NASDAQ: NUWE) seeks warrant share and reverse split votes - Stock Titan
Nuwellis to showcase Aquadex therapy at KidneyB... - Pluang
Nuwellis to Showcase Aquadex Therapy at KidneyBee Summit 2026 - The Manila Times
Nuwellis takes Aquadex to a pediatric kidney conference in Colorado - Stock Titan
NUWE Q1 2026 Earnings: Significant EPS Miss Highlights Persistent Cost PressuresBuyback Announcement Report - dars.gov.et
NUWENuwellis Inc Short Interest - Finviz
Nuwellis (NASDAQ: NUWE) CEO McCormick files initial insider Form 3 - Stock Titan
NUWE Q1 2026 Earnings: EPS Miss of 104.9% Sends Shares LowerNext Quarter Guidance - dars.gov.et
Nuwellis Inc (FRA:22S1) Stock Forecast, Price Targets and Analysts Predictions - GuruFocus
CHF Solutions, Inc.Special Call Transcript - GuruFocus
Nuwellis Inc (FRA:22S1) Stock Price & 30 Year Financial Data - GuruFocus
Price to cash flow ratio of Nuwellis, Inc. – FWB:22S1 - TradingView
Average basic shares outstanding of Nuwellis, Inc. – FWB:22S1 - TradingView
Net income of Nuwellis, Inc. – FWB:22S1 - TradingView
NUWELL.INC.NEW26 DL-,0001 Financial Statements – FWB:22S1 - TradingView
Nuwellis, Inc. Income Statement – FWB:22S1 - TradingView
Enterprise value to EBITDA forward of Nuwellis, Inc. – NASDAQ:NUWE - TradingView
Q1 2026 Nuwellis Inc Earnings Call Transcript - GuruFocus
Price to earnings forward of Nuwellis, Inc. – NASDAQ:NUWE - TradingView
Price to book forward of Nuwellis, Inc. – NASDAQ:NUWE - TradingView
Nuwellis Inc (STU:22S1) DCF Valuation - GuruFocus
Nuwellis Inc (STU:22S1) Stock Price & 30 Year Financial Data - GuruFocus
Nuwellis Inc (STU:22S1) Stock Earnings Transcripts - GuruFocus
Enterprise value to revenue forward of Nuwellis, Inc. – NASDAQ:NUWE - TradingView
Enterprise value to EBIT forward of Nuwellis, Inc. – NASDAQ:NUWE - TradingView
Form PRE 14A Nuwellis Inc For: 26 June - Investing.com UK
Price to sales forward of Nuwellis, Inc. – NASDAQ:NUWE - TradingView
Form PRE 14A Nuwellis Inc For: 26 June By Investing.com - Investing.com Nigeria
Nuwellis marks 5 years supporting pediatric car... - Pluang
Nuwellis (NUWE) asks shareholders to OK 2.4M warrant shares, reverse split option - Stock Titan
Nuwellis Stock Short Interest Falls to 42.32% - Quiver Quantitative
Nuwellis Marks Five Years of Support for PC4 Annual Conference to Advance Pediatric Cardiac Critical Care Education - Quiver Quantitative
Nuwellis Celebrates Five Years of Support of the Pediatric Cardiac Critical Care Consortium (PC⁴) - The Manila Times
Nuwellis Celebrates Five Years of Support of the Pediatric Cardiac Critical Care Consortium (PC⁴) - GlobeNewswire Inc.
Nuwellis, Inc. Actuals & Estimates (NASDAQ:NUWE) - TradingView
Nuwellis installs systems at Michigan pediatric facility - Investing.com UK
Nuwellis installs systems at Michigan pediatric facility By Investing.com - Investing.com South Africa
Nuwellis Announces Pediatric Expansion in Michigan with First Aquadex SmartFlow® Installations - The Manila Times
Nuwellis lands first pediatric Aquadex program in Michigan - Stock Titan
Nuwellis’ REVERSE-HF Trial Termination: What It Means for NUWE Investors - TipRanks
Nuwellis CEO outlines growth strategy focusing on pediatric market expansion and improved margins. - Pluang
Nuwellis Reviews 2026 Progress and Outlines Growth Priorities in Shareholder Letter From Incoming CEO Mike McCormick - Moomoo
Nuwellis Reviews 2026 Progress and Outlines Growth Priorities in Shareholder Letter from Incoming CEO Mike McCormick - Quiver Quantitative
Incoming Nuwellis CEO Mike McCormick Underscores Strategic Priorities for Continued Market Expansion in Pediatric Category and Revenue Generation in Letter to Shareholders - The Manila Times
Press Release: Incoming Nuwellis CEO Mike McCormick Underscores Strategic Priorities for Continued Market Expansion in Pediatric Category and Revenue Generation in Letter to Shareholders - Moomoo
According to documents submitted to the SEC, medical technology company Nuwellis, Inc. announced that its board of directors has approved a 1-for-10 reverse stock split plan, which will officially take effect on June 25, 2026. - Bitget
NuwellisOn June 16, Approves One-For-Thirty-Five Reverse Stock Split Of Common StockSEC Filing - TradingView
Nuwellis, Inc. Announces Reverse Stock Split Approval and Amendment to Certificate of Incorporation - Minichart
Nuwellis Inc Stock (NUWE) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.36%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):